International Business Machines Corporation (NYSE:IBM) [Trend Analysis] moved up reacts as active mover, shares a gain 0.16% to traded at $160.26 and the percentage gap between open changing to regular change was 0.21%. IBM (NYSE:IBM) revealed new, cost-conscious, enterprise class, all-flash storage designed to provide small, midsized organizations and global enterprises with primary storage for cloud or cognitive applications and workloads.
Also revealed is IBM’s “Flash In,” a storage migration program designed to help companies looking to leverage IBM’s expertise, like Dell and EMC clients, easily transition to IBM storage solutions as part of a journey to become cloud and cognitive businesses. Clients are embracing all-flash storage to deliver speed and response times necessary to support growing data workloads across public, private and hybrid cloud environments, as well as the demands of cognitive applications and workloads.
IBM Storwize V7000F and IBM Storwize 5030F are all-flash arrays that meet the needs across the wide breadth of primary storage applications, workload and use cases at cost effective price points. The firm’s current ratio calculated as 1.30 for the most recent quarter. The firm past twelve months price to sales ratio was 1.92 and price to cash ratio remained 14.55. As far as the returns are concern, the return on equity was recorded as 82.00% and return on investment was 23.40% while its return on asset stayed at 10.50%. The firm has total debt to equity ratio measured as 2.83.
Jacobs Engineering Group Inc. (NYSE:JEC) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with 1.02% to $54.64. Jacobs Engineering Group Inc. (JEC) revealed that it was awarded a contract to lead design and provide engineering services, procurement and construction support for Pfizer, Inc.’s new $350 million Global Biotechnology Center investment in the Hangzhou Economic Development Area in China.
Under the terms of the agreement, Jacobs is responsible for developing the overall site design, which includes aseptic fill/finish, drug substance and central utility buildings, a quality laboratory; administration offices, and a warehouse. The facility is being built to produce monoclonal antibodies and also serve as a process development and clinical supply site for biologic medicines in China. The share price of JEC attracts active investors, as stock price of week volatility recorded 1.40%. The stock is going forward to its 52-week low with 57.19% and lagging behind from its 52-week high price with -2.24%.
YY Inc. (NASDAQ:YY) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it 0.95% to close at $50.83 with the total traded volume of 2.21 Million shares. The firm has institutional ownership of 58.80%, while insider ownership included 14.95%. Its price to sales ratio ended at 3.06. YY attains analyst recommendation of 2.00 with week performance of 4.63%.